|
KMID : 1033620210480040295
|
|
Clinical and Experimental Reproductive Medicine
2021 Volume.48 No. 4 p.295 ~ p.302
|
|
|
Glucocorticoid therapy in assisted reproduction
|
|
Kim Yong-Jin
|
|
|
Abstract
|
|
|
|
As glucocorticoids are well-known as important regulators of stress and the immune system, their function and clinical use have elicited substantial interest in the field of reproduction. In particular, the effect of glucocorticoid therapy on endometrial receptivity during assisted reproduction, including in vitro fertilization (IVF) cycles, has led to a great deal of interest and controversy. However, previous studies have not been able to provide consistent and reliable evidence due to their small, non-controlled designs and use of different criteria. Considering the potential risk of exposure to glucocorticoids for mothers and fetuses in early pregnancy, the use of glucocorticoids in IVF cycles should be carefully evaluated, including the balance between risk and benefit. To date, there is no conclusive evidence that the use of glucocorticoids improves the pregnancy rate in IVF cycles with unselected subjects, and a further investigation should be considered with a proper study design.
|
|
|
KEYWORD
|
|
|
In vitro fertilization, Glucocorticoids, Pregnancy rate, Receptivity
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|